Article

Erythrotropin for Treating Anemia in Multiple Myeloma: Response to Treatment and Survival

2020-07-09

Abstract excerpt

<h4>Background: </h4> Anemia is a common complication of multiple myeloma (MM). Recombinant human erythropoietin (rhEPO) and blood transfusions are two general treatments for anemia. Methods In a retrospective study, we compared the efficacy and treatment response of rhEPO to those of blood transfusions on anemia and sought to determine its prognostic value in for these patients. The 94 patients who received rhEP...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 59f25c58-2bd8-50ce-8031-33b2d319b53f
DOI: 10.21203/rs.3.rs-35660/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Erythrotropin for Treating Anemia in Multiple Myeloma: Response to Treatment and SurvivalDOI 10.21203/rs.3.rs-35660/v1Read

Haematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-line Treatment With a Bortezomib-based RegimenSemantic proximity Read

Hematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-Line Treatment With A Bortezomib-Based RegimenSemantic proximity Read

Cancer-related anemia and recombinant human erythropoietin—an updated overviewSemantic proximity Read

Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answersSemantic proximity Read

Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agentsSemantic proximity Read

Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study.Semantic proximity Read

Therapeutic Effects of Genetically Modified Wharton’s Jelly Mesenchymal Stem Cells Expressing Erythropoietin on Breast Cancer-related Anemia in Mice ModelSemantic proximity Read

The partial erythropoietin receptor agonist ML1-R is a potent neuroprotective drug with a distinct signaling profile.Semantic proximity Read

Recombinant human erythropoietin and the anemia of cancer [editorial]Semantic proximity Read

Recombinant human erythropoietin and the anemia of cancer [editorial]Semantic proximity Read

Erythroid marrow activity and hemoglobin H levels in hemoglobin H disease.Semantic proximity Read

Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects?Semantic proximity Read